Effect of hepatic arterial infusion chemotherapy of 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma in the Nationwide Survey of Primary Liver Cancer in Japan.
about
Current Status of Hepatic Arterial Infusion ChemotherapyPhase I/II Study of Sorafenib in Combination with Hepatic Arterial Infusion Chemotherapy Using Low-Dose Cisplatin and 5-FluorouracilA Phase I/II trial of continuous hepatic intra-arterial infusion of 5-fluorouracil, mitoxantrone and cisplatin for advanced hepatocellular carcinoma.Hepatic arterial infusion chemotherapy for patients with huge unresectable hepatocellular carcinoma.A new therapeutic assessment score for advanced hepatocellular carcinoma patients receiving hepatic arterial infusion chemotherapy.Consensus Development from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014).Rapid and early α-fetoprotein and des-γ-carboxy prothrombin responses to initial arterial infusion chemotherapy predict treatment outcomes of advanced hepatocellular carcinoma.Evaluation of sorafenib treatment and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: a comparative study using the propensity score matching method.A 5-fluorouracil-loaded floating gastroretentive hollow microsphere: development, pharmacokinetic in rabbits, and biodistribution in tumor-bearing miceCharacteristics of patients with liver cancer in the BioBank Japan project.Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma.Report of the 19th follow-up survey of primary liver cancer in Japan.Efficacy of iron chelator deferoxamine for hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma patients refractory to current treatments.Retrograde-outflow percutaneous isolated hepatic perfusion using cisplatin: A pilot study on pharmacokinetics and feasibility.Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study.Hepatocellular Carcinoma with Macrovascular Invasion: Defining the Optimal Treatment Strategy.Chemotherapy for hepatocellular carcinoma: current status and future perspectives.Evaluation of the "assessment for continuous treatment with hepatic arterial infusion chemotherapy" scoring system in patients with advanced hepatocellular carcinoma.Efficacy of hepatic arterial infusion chemotherapy in combination with irradiation for advanced hepatocellular carcinoma with portal vein invasion.Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): an open label, non-comparative, phase II trial.Treatment strategies for advanced hepatocellular carcinoma: Sorafenib hepatic arterial infusion chemotherapyEfficacy of sequential sorafenib plus hepatic arterial infusion chemotherapy in patients with Barcelona Clinic Liver Cancer stage B and C hepatocellular carcinoma: a retrospective single-institution study
P2860
Q26775437-CF9BB1EE-2ADA-4489-AE0A-3B38A530A86EQ33428936-5282E753-27DF-4061-A627-D8F5850794D8Q33440349-9B2F6A6E-2588-4214-BDFE-FCC857E40C5AQ33604270-00996871-B9E9-406E-BEB0-DC1AA6B44CE0Q35629299-329FFF11-0E8D-453F-A944-3E755302A963Q35631270-FC931F09-3C89-4930-BB83-C5A7C4223EC3Q35753801-B8C55D06-B970-408D-A914-372E4DB31B21Q36023884-2D9379F3-4E9B-4E85-A39B-1A3204C09256Q36659308-BFE98149-E898-42B4-9B52-F8E5190F0D62Q37700221-71ECC0C6-B282-49AB-9EA0-74274BB785C6Q38410821-00C97930-AB3A-40E6-AFA6-3FAFE7A7F125Q38896146-6F278A7A-A60D-4128-ACB8-215DD3FF7CB2Q38982079-701A7650-74D3-49BD-B049-03F9DECD3B56Q40244441-DDB440ED-3E57-4209-B67F-84DC623C9A22Q42332098-95052930-800B-418C-9EA7-744FA93E0FDEQ42644010-0893930F-B842-482D-8A3B-84C88406D812Q47320483-3BC1CF2B-CE10-483F-AB89-24F35B2F036AQ47775953-2C19BD9F-BA57-49BB-81FD-759616658926Q50557536-BD7ECBF6-01F4-4F62-8848-D096480958E2Q53573051-136A1594-1206-483E-9A18-E927E85FED41Q55491540-8617D5C7-60D4-41D5-A21C-17D730EFE0E8Q57491231-DB208CCE-DC2A-4AE2-BDD1-044573B679FEQ59129080-17EEB82E-7DCA-4645-8F38-863280DEC454
P2860
Effect of hepatic arterial infusion chemotherapy of 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma in the Nationwide Survey of Primary Liver Cancer in Japan.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effect of hepatic arterial inf ...... Primary Liver Cancer in Japan.
@en
Effect of hepatic arterial inf ...... Primary Liver Cancer in Japan.
@nl
type
label
Effect of hepatic arterial inf ...... Primary Liver Cancer in Japan.
@en
Effect of hepatic arterial inf ...... Primary Liver Cancer in Japan.
@nl
prefLabel
Effect of hepatic arterial inf ...... Primary Liver Cancer in Japan.
@en
Effect of hepatic arterial inf ...... Primary Liver Cancer in Japan.
@nl
P2093
P2860
P356
P1476
Effect of hepatic arterial inf ...... Primary Liver Cancer in Japan.
@en
P2093
K Miyahara
K Yamamoto
Liver Cancer Study Group of Japan
M Sakamoto
P2860
P2888
P304
P356
10.1038/BJC.2013.542
P407
P577
2013-09-05T00:00:00Z